483
Institute for Reproductive HealthInstitute for Reproductive Health – FDA 483, Aug 30, 2023
Record Details
An FDA inspection of Institute for Reproductive Health in Cincinnati, OH, revealed significant deficiencies in their donor screening process for communicable disease agents. The firm's donor history questionnaire for oocyte donors was found to be inadequate, failing to properly address risk factors for conditions such as Creutzfeldt-Jacob disease and Zika virus. This indicates a failure to ensure the safety of human cells, tissues, and cellular and tissue-based products (HCT/Ps).
- Person
View Company Profile
ID · 6cc43809-2c81-4529-b297-c0fb6e23e608
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.